Redox imbalance

Cell and Tissue Research
Daniela BergPeter Riederer

Abstract

Substantial evidence implies that redox imbalance attributable to an overproduction of reactive oxygen species or reactive nitrogen species that overwhelm the protective defense mechanism of cells contributes to all forms of Parkinson's disease. Factors such as dopamine, neuromelanin, and transition metals may, under certain circumstances, contribute to the formation of oxygen species such as H(2)O(2), superoxide radicals, and hydroxyl radicals and react with reactive nitrogen species such as nitric oxide or peroxinitrite. Mitochodrial dysfunction and excitotoxicity may be a cause and a result of oxidative stress. Consequences of this redox imbalance are lipid peroxidation, oxidation of proteins, DNA damage, and interference of reactive oxygen species with signal transduction pathways. These consequences become even more harmful when genetic variations impair the normal degradation of altered proteins. Therefore, therapeutic strategies must aim at reducing free-radical formation and scavenging free-radicals.

References

Feb 1, 1975·Archives of Neurology·L M AmbaniS Murphy
Sep 1, 1992·Journal of Neurochemistry·K JellingerM B Youdim
Jan 16, 1992·Biochimica Et Biophysica Acta·L ZeccaE Parati
Nov 1, 1991·Journal of Neurochemistry·D Ben-ShacharM B Youdim
Dec 1, 1990·Archives of Biochemistry and Biophysics·D W Reif, R D Simmons
Sep 29, 1989·Biochemical and Biophysical Research Communications·Y MizunoY Kagawa
Oct 1, 1989·Annals of Neurology·D SchermanY Agid
Feb 1, 1989·Journal of Neurochemistry·D T DexterC D Marsden
Feb 1, 1989·Journal of Neurochemistry·P RiedererM B Youdim
Apr 1, 1987·Neurology·J R Sanchez-RamosW J Weiner
Aug 5, 1985·Neuroscience Letters·S J KishO Hornykiewicz
Sep 1, 1994·Journal of Neurochemistry·M GerlachM B Youdim
Jan 1, 1994·Pharmacology & Therapeutics·M E GötzM B Youdim
Sep 1, 1994·Annals of Neurology·J SianC D Marsden
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·L Zecca, H M Swartz
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·M B YoudimP Riederer
Jan 1, 1993·Neuroscience·P DamierF Javoy-Agid
Mar 21, 1996·Nature·D M GashG A Gerhardt
Jul 1, 1996·Chemical Research in Toxicology·J S Beckman
Jan 1, 1997·Molecular Aspects of Medicine·E StrijksM W Horstink
Nov 14, 1997·The Journal of Biological Chemistry·J Jahngen-HodgeA Taylor
Mar 26, 1998·Experimental Neurology·H M SchipperE G Stopa
Aug 28, 1998·Journal of Neural Transmission·F J Jiménez-JiménezM C Martínez-Para
Sep 28, 1998·Annals of Neurology·P Jenner, C W Olanow
Apr 1, 1999·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·L ForsleffS Stuart

❮ Previous
Next ❯

Citations

Feb 9, 2006·Neurotoxicity Research·Daniela BergOlaf Riess
Dec 27, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kelly A MeulendykeM Christine Zink
Jul 1, 2009·Indian Journal of Clinical Biochemistry : IJCB·G Sharmila BanuA G Murugesan
Jun 19, 2013·Critical Reviews in Food Science and Nutrition·Muhammad AbrarKhalid Waqas
Apr 11, 2006·Neuroreport·Mariana Angoa-PérezSelva Rivas-Arancibia
Dec 21, 2006·Topics in Magnetic Resonance Imaging : TMRI·John F SchenckTimothy O'Keefe
Jul 14, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kathleen E DennisCandice D Fike
Oct 1, 2008·Biomarkers in Medicine·Mauro FasanoLeonardo Lopiano
Sep 6, 2012·International Journal of Molecular Sciences·Hemant KumarDong-Kug Choi
Jun 21, 2014·Pharmacological Reports : PR·Aleksandra GoleniaAgnieszka Słowik
Feb 27, 2010·Expert Opinion on Therapeutic Targets·Victoria S BurchellHélène Plun-Favreau
May 10, 2008·Expert Review of Proteomics·Mauro Fasano, Leonardo Lopiano
Apr 7, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Weiwei MaRong Xiao
Jul 1, 2008·Parkinsonism & Related Disorders·Mauro FasanoLeonardo Lopiano
Mar 25, 2008·Biochimica Et Biophysica Acta·Shankar J Chinta, Julie K Andersen
Jul 31, 2007·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·F GagnéC Blaise
Apr 19, 2008·Journal of Cellular and Molecular Medicine·Teresa IuvoneMaurizio Guida
Nov 1, 2007·Proteomics. Clinical Applications·Mauro FasanoLeonardo Lopiano
Apr 28, 2011·Fundamental & Clinical Pharmacology·Marcos Roberto de OliveiraJosé Cláudio Fonseca Moreira
Aug 15, 2009·Journal of Neuroscience Research·Victor TapiasJ Timothy Greenamyre
Aug 4, 2006·Nitric Oxide : Biology and Chemistry·Hyun-Ae EumSun-Mee Lee
May 30, 2006·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·S P PreethaP Varalakshmi
Apr 8, 2006·Archives of Biochemistry and Biophysics·Muralidhar L HegdeK S Jagannatha Rao
Dec 6, 2005·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Giovanni ForteBeatrice Bocca
Jun 27, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimBrian E Leonard
Mar 9, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jing Qin WuXiang Yang Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.